drugset / Trial / NCT00185003
Blockade of Vascular Potassium Channels During Human Endotoxemia
Phase 1
Completed
36 enrolled
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Background: Activation of NO-synthase and vascular potassium (K) channels may play a role in the sepsis-induced attenuated sensitivity to norepinephrine. We examined whether various K channel blockers and NO-synthase inhibition could restore norepinephrine sensitivity during experimental human endotoxemia.
Timeline
- Start
- 2003-01
- Primary completion
- 2005-06
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-NMMA | Unknown | 0.2 unknown | Other |
| Subject | Quinin | Unknown | — | — |
| Subject | Tetraethylammonium | Unknown | — | Other |
| Subject | Tolbutamide | Small molecule | — | — |
Indications
No indication recorded.